Immuron IMRN
NASDAQ IMRN
$1.09 -0.04 (-3.54%)
At close: Oct 2, 2026 · 4:00 PM EDT

Immuron (IMRN) Return on Assets [ROA] (2021 - 2026)

Updated

Immuron's Return on Assets [ROA] came in at -34.87% for FY2026 (year ended Aug 28, 2026), down 33.29 percentage points from -1.58% in FY2025.

Analysis

Immuron (IMRN) Return on Assets [ROA] (2021 - 2026) Analysis & Trends

Going back to FY2016, Immuron's Return on Assets [ROA] data covers 11 fiscal years.

  • Return on Assets [ROA] carries a five-year change of +10.29 percentage points (FY2021 to FY2026).
  • The five-year range for annual Return on Assets [ROA] is -53.53% (FY2024) to -1.58% (FY2025).
  • Per Business Quant, earlier fiscal years put Return on Assets [ROA] at -1.58% in FY2025, -53.53% in FY2024 (-41.52 pp), -12.01% in FY2023 (-2.35 pp) and -9.66% in FY2022 (+35.49 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Immuron 8.80 Mn -8.50 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -6.08%
Jun 30, 2025 -47.32%
Dec 31, 2024 -63.06%
Sep 9, 2024 -143.66%
Jun 30, 2024 -266.84%
Dec 31, 2023 -43.10%
Dec 31, 2022 -49.92%
Jun 30, 2021 -66.51%
API Access

Immuron Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=IMRN&period=max&api_key=YOUR_API_KEY